Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Improving Response Assessment in Cancer by Measurement of Cellular Redox Status Using 18F-FSPG Positron Emission Tomography

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05889312
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:38.712188+00:00
Published At
2025-04-04T00:00:00+00:00
Record Updated At
2025-04-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cancer", "Diagnosis", "Resistant Cancer", "Response, Acute Phase"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-04"
protocolSection.identificationModule.nctId
"NCT05889312"
protocolSection.identificationModule.officialTitle
"Improving Response Assessment in Cancer by Measurement of Cellular Redox Status Using 18F-FSPG Positron Emission Tomography"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cancer (protocolSection.conditionsModule.conditions)
  • Diagnosis (protocolSection.conditionsModule.conditions)
  • Resistant Cancer (protocolSection.conditionsModule.conditions)
  • Response, Acute Phase (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.